Do you ever experience red or itchy eyelids and can’t wear your soft contact lenses as long as you wish? If so, you may qualify for our upcoming research study….
LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension,…
Orasis Pharmaceuticals Announces FDA Approval of QLOSI™ (pilocarpine hydrochloride ophthalmic solution) 0.4% for the Treatment of Presbyopia Ponte Vedra, FL, October 18, 2023 QLOSI (pronounced CLOH-see) is a prescription eye…
For Immediate Release – July 25, 2023 Tarsus Pharmaceuticals, Inc, Irvine, CA, announced the U.S. Food and Drug Administration (FDA) has approved XDEMVY (lotilaner ophthalmic solution) 0.25% indicated for the…
We invite you to join a clinical trial evaluating an investigational eye drop for treating Presbyopia, an age-related condition making it difficult to see things up-close To participate in this…